Angela J Okragly

Title: Angela J Okragly: Innovator in Non-Invasive Diagnostics

Introduction

Angela J Okragly is a prominent inventor based in Madison, WI (US). She has made significant contributions to the field of medical diagnostics, particularly in the area of interstitial cystitis and bladder cancer. Her innovative approach focuses on non-invasive methods that enhance patient care and diagnosis.

Latest Patents

Angela holds a patent for a non-invasive diagnostic method for interstitial cystitis and bladder cancer. The patent discloses a method that involves analyzing the urine of a mammal for the concentration of specific urine-soluble proteins. These proteins include neurotrophin-3, nerve growth factor, glial cell line-derived neurotrophic factor, and tryptase, among others. This groundbreaking method has the potential to revolutionize how these conditions are diagnosed and monitored.

Career Highlights

Angela is currently associated with Promega Corporation, where she continues to work on innovative solutions in diagnostics. Her dedication to research and development has positioned her as a key player in her field. With 1 patent to her name, she exemplifies the spirit of innovation that drives advancements in medical technology.

Collaborations

Angela has collaborated with notable colleagues, including Andrew L Niles and Mary Haak-Frendscho. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Angela J Okragly's contributions to non-invasive diagnostic methods highlight her commitment to improving healthcare outcomes. Her work not only advances medical science but also enhances the quality of life for patients.